OMB control number
Prescription Drug Marketing: Administrative Procedures, Policies, and Requirements
OMB 0910-0435 · HHS/FDA.
OMB 0910-0435
This information collection supports implementation of the Prescription Drug Marketing Act and FDA regulations. The regulations are intended to protect the public against the threat of subpotent, adulterated, counterfeit, and misbranded drugs posed by the existence of drug diversion schemes and a drug diversion submarket, and the absence of appropriate controls over and creation and maintenance of appropriate records regarding the distribution of prescription drugs.
The latest form for Prescription Drug Marketing: Administrative Procedures, Policies, and Requirements expires 2028-02-29 and is listed under ICR 202502-0910-009.
Latest Forms, Documents, and Supporting Material
| Document | Type |
|---|---|
| Form | |
| Form | |
| Justification for No Material/Nonsubstantive Change | |
| Justification for No Material/Nonsubstantive Change | |
| Supporting Statement A | |
| Supporting Statement A | |
| Form | |
| Form | |
| Instruction | |
| Information collection |
All Historical Document Collections
OMB Details
Prescription Drug Marketing: Reporting
Federal Enterprise Architecture: Health - Public Health Monitoring
| Form | Name | Electronic access | Type |
|---|---|---|---|
| Form | www.fda.gov/about-fda/reports-manuals-forms/forms | Instruction | |
| Form 3911 | Drug Notification | www.fda.gov/about-fda/reports-manuals-forms/forms | Form |
Review document collections for all forms, instructions, and supporting documents - including paper/printable forms.